ArticleFrontiers in artificial intelligence2026
PRIMED: predicting DNA binding residues by leveraging pre-trained protein language models.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Introduction: Protein-DNA interactions are central to gene regulation, genome stability, and disease mechanisms. Identifying DNA-binding residues (DBRs) is critical for structural modeling, protein engineering, and therapeutic design. Although experimental approaches provide valuable insights, they remain low-throughput and resource-intensive. Computational methods offer scalable alternatives by leveraging protein sequential and structural information to predict DBRs. Methods: We present PRIMED (Protein Residue Inference using Multilayer perceptron for Enhanced DNA-binding predictions), a machine learning framework that integrates protein representations of distinct biochemical and structural properties from three protein language models: ESM-2, ESM-3, and ESM-C. These representations are concatenated and processed by a multilayer perceptron to perform DBR predictions. Results: PRIMED demonstrated strong performance across three benchmark datasets: Test-46 and Test-129 from a previous study, CLAPE-DB, and Test-10 K, which we curated from UniProtKB/Swiss-Prot. The model achieves an area under the Receiver Operating Characteristic curve (AUC) of 0.92 and a Matthews Correlation Coefficient (MCC) of 0.64 on Test-46, as well as an AUC of 0.93 and MCC of 0.45 on Test-129. On Test-10 K, PRIMED demonstrates generalizability across proteins with varying DBR percentages, maintaining competitive performance relative to the runner-up method, CLAPE-DB. Discussion: These results highlight the effectiveness of integrating diverse protein language model representations for accurate, transferable DBR predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.